31 unknown. 31 Phase 2, 8 Phase 3, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 31 | Unknown 31 |
| Phase 3 | 8 | Unknown 8 |
| Phase 1 | 4 | Unknown 4 |
Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma Salbutamol, Fluticason either Beclometasone or Budesonide - Asthma | Phase 2 | Unknown | Università degli Studi di Ferrara | 80 | 2024-06-18 | 2024-07-03 |
| Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma Tezepelumab, Placebo - Asthma, Allergic | Phase 2 | Unknown | McMaster University | 34 | 2023-04-01 | 2023-02-23 |
| Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults Antipyrine-benzocaine otic solution, Glycerin with Oxyquinoline Sulfate - Asthma | Phase 2 | Unknown | Global United Pharmaceutical Corporation | 50 | 2023-04-01 | 2023-02-08 |
| A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma 610 100mg, 610 300mg, placebo - Asthma | Phase 2 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 120 | 2022-09-01 | 2022-09-06 |
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma GR1802 injection, Placebo - Asthma | Phase 2 | Unknown | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 150 | 2022-07-19 | 2024-10-15 |
| A Study of MG-K10 in Subjects With Asthma MG-K10, Placebo - Asthma | Phase 1 / Phase 2 | Unknown | Shanghai Mabgeek Biotech.Co.Ltd | 180 | 2022-07-05 | 2023-08-21 |
| Benralizumab Initiated During Severe Asthma Attack Benralizumab 30 MG/ML [Fasenra], Placebos - Asthma Attack, Asthma | Phase 2 | Unknown | Singapore General Hospital | 128 | 2021-06-02 | 2021-07-23 |
| Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) Benralizumab, Prednisolone - Asthma, COPD | Phase 2 | Unknown | University of Oxford | 158 | 2021-03-29 | 2024-01-23 |
| A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang Weiyang Yuping Fang - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 84 | 2020-10-01 | 2023-05-25 |
| Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics Magnesium Sulfate, Placebo - Asthma in Children | Phase 2 / Phase 3 | Unknown | Oman Medical Speciality Board | 90 | 2020-08-01 | 2020-07-13 |
| Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline Minocycline Topical, Placebos - Allergic Rhinitis, Asthma | Phase 2 | Unknown | State University of New York - Downstate Medical Center | 25 | 2019-09-26 | 2021-10-14 |
| Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis S-1226 - Cystic Fibrosis, Bronchiectasis | Phase 2 | Unknown | SolAeroMed Inc. | 12 | 2019-08-08 | 2021-06-16 |
| Clinical Study on Treatment of Chronic Persistent Bronchial Asthma Ke Chuan Liu Wei Granule, Yang He Ping Chuan Granule, Ke Chuan Liu Wei Granule placebo - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 320 | 2018-02-01 | 2023-05-25 |
| Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules. Chanqin granules - Cough Variant Asthma | Phase 1 / Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 120 | 2017-11-01 | 2017-10-24 |
| A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma Jia Wei Yang He granule, Jia Wei Yang He granule Placebo - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 240 | 2017-10-01 | 2024-05-07 |
| Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine Ke Chuan Liu Wei Mixture, Chuan Xiong Ping Chuan Mixture, Xie Wu Capsule - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 288 | 2017-07-30 | 2020-02-26 |
| The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions Allergen(Tree, Grass, Weeds) - Allergic Rhinitis, Asthma | Phase 1 / Phase 2 | Unknown | University Hospitals Cleveland Medical Center | 245 | 2013-04-01 | 2013-06-17 |
| Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma Ambrisentan, Bosentan, Placebo - Asthma | Phase 2 | Unknown | University of Glasgow | 18 | 2012-11-01 | 2012-06-12 |
| Safety and Efficacy of the Inspiromatic Inhaler in Comparison to the Aerolizer Inhaler When Delivering Formoterol Aerolizer Followed by Inspiromatic, Inspiromatic followed by Aerolizer - Asthma | Phase 1 / Phase 2 | Unknown | Guy Steuer | 30 | 2012-10-01 | 2012-10-22 |
| Effects of Montelukast on Airway Regulatory T Cells in Asthma Montelukast - Asthma | Phase 2 / Phase 3 | Unknown | Kurume University | 15 | 2012-06-01 | 2013-09-27 |
Showing 20 of 31. Sign in to see all of them.
Conjunctivitis, Allergic (2) · Pulmonary Disease, Chronic Obstructive (2) · Rhinitis, Allergic (2) · Status Asthmaticus (2) · Bronchiectasis (1) · Cough-Variant Asthma (1) · Cystic Fibrosis (1) · Dermatitis, Atopic (1) · Food Hypersensitivity (1) · Hypersensitivity (1) · Inflammation (1) · Lung Diseases, Obstructive (1) · Pulmonary Eosinophilia (1) · Respiratory Hypersensitivity (1)
Bronchial Diseases (31) · Hypersensitivity, Immediate (31) · Immune System Diseases (31) · Lung Diseases (31) · Respiratory Tract Diseases (31) · Hypersensitivity (30) · Lung Diseases, Obstructive (30) · Respiratory Hypersensitivity (30) · Nose Diseases (3) · Otorhinolaryngologic Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Rhinitis (3) · Chronic Disease (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)
montelukast (4) · Budesonide (2) · Formoterol Fumarate (2) · benralizumab (2) · Albuterol (1) · Beclomethasone (1) · Bosentan (1) · EA 575 extract (1) · Glycerol (1) · Magnesium Sulfate (1) · Minocycline (1) · Omalizumab (1) · Orthomolecular Therapy (1) · Oxyquinoline (1) · Prednisolone (1)
Shanghai University of Traditional Chinese Medicine (5) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Canadian Institute of Natural and Integrative Medicine (1) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. (1) · Glenmark Pharmaceuticals Europe Ltd. (R&D) (1) · Global United Pharmaceutical Corporation (1) · Guy Steuer (1) · King's College London (1) · Kurume University (1) · McMaster University (1) · Medical University of Lodz (1) · NovaMed Pharmaceuticals Inc. (1) · Oman Medical Speciality Board (1) · Shanghai Mabgeek Biotech.Co.Ltd (1) · Singapore General Hospital (1)
China (9) · United States (6) · United Kingdom (4) · Canada (3) · Finland (1) · Germany (1) · India (1) · Israel (1) · Italy (1) · Japan (1) · Poland (1) · Singapore (1)
Zhenhui Lu, Doctor (2) · Agnieszka Brzozowska, MD, PhD (1) · Alberto Papi, MD (1) · Andrew Wilson, MD, MRCP (UK) (1) · Badri Rickhi, MB,BS,FRCPC (1) · Christopher Corrigan, MD, PhD (1) · Devi K Jhaveri, D.O. (1) · Eric Arrata, ND (1) · Erkki Savilahti, Professor (1) · Gail Gauvreau, PhD (1) · Guy Steuer, M.D. (1) · Haig Tcheurekdjian, M.D. (1) · Hude Quan, MD, PhD (1) · Huiyong Zhang, Director (1)
PMID 16164444, PMID 18595980, PMID 21771118, PMID 22093109, PMID 25445859, PMID 27609406, PMID 27609408, PMID 27824606, PMID 29973284, PMID 30326954, PMID 30472801, PMID 31310686, PMID 34857814, PMID 37438187, PMID 38687061, PMID 39615502, PMID 42212541
2009 (1), 2018 (1)